Hackanson B - Search Results

1

[Epigenetic therapy in myelodysplastic syndromes (MDS). Treatment with DNA methyltransferase inhibitors].

Daskalakis M, Blagitko-Dorfs N, Hackanson B, Lübbert M. Daskalakis M, et al. Among authors: hackanson b. Pharm Unserer Zeit. 2010 May;39(3):217-27. doi: 10.1002/pauz.201000369. Pharm Unserer Zeit. 2010. PMID: 20425776 Review. German. No abstract available.

2

The silence of the genes: epigenetic disturbances in haematopoietic malignancies.

Hackanson B, Guo Y, Lübbert M. Hackanson B, et al. Expert Opin Ther Targets. 2005 Feb;9(1):45-61. doi: 10.1517/14728222.9.1.45. Expert Opin Ther Targets. 2005. PMID: 15757481 Review.

3

Characterization of DNA demethylation effects induced by 5-Aza-2'-deoxycytidine in patients with myelodysplastic syndrome.

Mund C, Hackanson B, Stresemann C, Lübbert M, Lyko F. Mund C, et al. Among authors: hackanson b. Cancer Res. 2005 Aug 15;65(16):7086-90. doi: 10.1158/0008-5472.CAN-05-0695. Cancer Res. 2005. PMID: 16103056

4

In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies.

Hackanson B, Robbel C, Wijermans P, Lübbert M. Hackanson B, et al. Ann Hematol. 2005 Dec;84 Suppl 1:32-8. doi: 10.1007/s00277-005-0004-1. Ann Hematol. 2005. PMID: 16292549 Review.

5

Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia.

Hackanson B, Bennett KL, Brena RM, Jiang J, Claus R, Chen SS, Blagitko-Dorfs N, Maharry K, Whitman SP, Schmittgen TD, Lübbert M, Marcucci G, Bloomfield CD, Plass C. Hackanson B, et al. Cancer Res. 2008 May 1;68(9):3142-51. doi: 10.1158/0008-5472.CAN-08-0483. Cancer Res. 2008. PMID: 18451139

6

XXIII International Association for Comparative Research on Leukemia and Related Diseases Symposium: from molecular pathogenesis to targeted therapy in leukemia and solid tumors.

Hackanson B, Becker H, Berg T, Binder M, Dierks C, Duque-Afonso J, Lairmore MD, Schäfer HS, Schnitzler M, Zeiser R, Martens U, Mertelsmann R, Lübbert M. Hackanson B, et al. Cancer Res. 2008 Jul 15;68(14):5512-8. doi: 10.1158/0008-5472.CAN-07-6859. Cancer Res. 2008. PMID: 18632600 Free PMC article. No abstract available.

7

Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML).

Hackanson B, Rückert A, Lübbert M. Hackanson B, et al. Eur J Haematol. 2009 Dec 1;83(6):611-2. doi: 10.1111/j.1600-0609.2009.01335.x. Epub 2009 Aug 13. Eur J Haematol. 2009. PMID: 19682063 Review. No abstract available.

8

Decitabine.

Daskalakis M, Blagitko-Dorfs N, Hackanson B. Daskalakis M, et al. Among authors: hackanson b. Recent Results Cancer Res. 2010;184:131-57. doi: 10.1007/978-3-642-01222-8_10. Recent Results Cancer Res. 2010. PMID: 20072836 Review.

9

NHR4 domain mutations of ETO are probably very infrequent in AML1-ETO positive myeloid leukemia cells.

Hackanson B, Abdelkarim M, Jansen JH, Lübbert M. Hackanson B, et al. Leukemia. 2010 Apr;24(4):860-1. doi: 10.1038/leu.2009.291. Epub 2010 Jan 21. Leukemia. 2010. PMID: 20090777 No abstract available.

10

Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy.

Wagner JM, Hackanson B, Lübbert M, Jung M. Wagner JM, et al. Among authors: hackanson b. Clin Epigenetics. 2010 Dec;1(3-4):117-136. doi: 10.1007/s13148-010-0012-4. Epub 2010 Nov 9. Clin Epigenetics. 2010. PMID: 21258646 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters